Inhibition of interleukin-12 expression in diltiazem-treated dendritic cells through the reduction of nuclear factor-κB transcriptional activity

Biochemical Pharmacology

Volumn 69, Issue 3, 2005, Pages 425-432

  Severa, Martina ^a   D'Ambrosio, Antonella ^a   Giordani, Luciana ^b   Quintieri, Francesca ^a   Coccia, Eliana ^a  

^a Immunomediated Dis Ist S ^*  (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

CD40L; Dendritic cells; Diltiazem; IL 12; Lipopolysaccharide; NF B

Indexed keywords

DILTIAZEM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12;

ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME DEGRADATION; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING;

ACTIVE TRANSPORT, CELL NUCLEUS; CD40 LIGAND; DENDRITIC CELLS; DILTIAZEM; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN SUBUNITS; PROTEIN TRANSPORT; TRANSCRIPTION, GENETIC;

EID: 12144257775     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.10.004     Document Type: Article

References (54)

1. M. May, and S. Ghosh Signal trasduction through NF-κB Immunol Today 1998 80 88
2. B. Zingarelli, M. Sheehan, and H. Wong Nuclear factor-kappaB as a therapeutic target in critical care medicine Crit Care Med 2003 105 111
3. J. Lee, R. Ganster, D. Geller, G. Burckart, A. Thomson, and L. Lu Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B Transplantation 1999 1255 1263
4. M. Karin, and M. Delhase The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling Semin Immunol 2000 85 98
5. G. Trinchieri Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 2003 133 146
6. M. Gately, L. Renzetti, J. Magram, A. Stern, L. Adorini, and U. Gubler The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol 1998 495 521
7. M. Cella, D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation J Exp Med 1996 747 752
8. J. Piccotti, S. Chan, R.E. Goodman, J. Magram, E. Eichwald, and D. Bishop IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection: evidence against a dominant protective role for T helper 2 cytokines in alloimmunity J Immunol 1996 1951 1957
9. J. Banchereau, and R. Steinman Dendritic cells and the control of immunity Nature 1998 245 252
10. M. Cella, F. Sallusto, and A. Lanzavecchia Origin, maturation, and antigen presenting function of dendritic cells Curr Opin Immunol 1997 10 16
11. T. Brocker, M. Riedinger, and K. Karjalainen Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo J Exp Med 1997 541 550
12. F. Finkelman, A. Lees, R. Birnbaum, W. Gause, and S. Morris Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion J Immunol 1996 1406 1414
13. R. Steinman, D. Hawiger, and M. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 2003 685 711
14. F. Ouaaz, J. Arron, Y. Zheng, Y. Choi, and A. Beg Dendritic cell development and survival require distinct NF-kappaB subunits Immunity 2002 257 270
15. L. Lu, and A. Thomson Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease Transplantation 2002 S19 S22
16. J. Lee, and G. Burckart Nuclear factor kappa B: important transcription factor and therapeutic target J Clin Pharmacol 1998 981 993
17. M. Marx, M. Weber, F. Merkel, K.M.z. Buschenfelde, and H. Kohler Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation Nephrol Dial Transplant 1990 1038 1044
18. J. Solovera, M. Alvarez-Mon, J. Casas, J. Carballido, and A. Durantez Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist J Immunol 1987 876 880
19. K. Chitwood, and K. Heim-Duthoy Immunosuppressive properties of calcium channel blockers Pharmacotherapy 1993 447 454
20. A. D'Ambrosio, G. Segoloni, and F. Quintieri The modulatory effect of diltiazem on human in vitro alloreactivity when used alone or in combination with cyclosporin A and/or methylprednisolone Transplant Int 1997 426 431
21. A.E.E.G. D'Ambrosio, E. Giacomini, B. Camponeschi, and F. Quintieri Diltiazem modulates monokine production in human mixed lymphocyte culture Transplantation 1998 1411 1413
22. A. Bachetoni, A. D'Ambrosio, P. Mariani, R. Cortesini, and F. Quintieri Diltiazem impairs maturation and functions of human dendritic cells Hum Immunol 2002 524 533
23. A. Chrysostomou, R. Walker, G. Russ, A. d'Apice, P. Kincaid-Smith, and T. Mathew Diltiazem in renal allograft recipients receiving cyclosporine Transplantation 1993 300 304
24. L. Piemonti, P. Monti, P. Allavena, M. Sironi, L. Soldini, and B. Leone Glucocorticoids affect human dendritic cell differentiation and maturation J Immunol 1999 6473 6481
25. N. Vanderheyde, V. Verhasselt, M. Goldman, and F. Willems Inhibition of human dendritic cell functions by methylprednisolone Transplantation 1999 1342 1347
26. M. Colic, Z. Stojic-Vukanic, B. Pavlovic, D. Jandric, and I. Stefanoska Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells Clin Exp Immunol 2003 63 69
27. E. Giacomini, E. Iona, L. Ferroni, M. Miettinen, L. Fattorini, and G. Orefici Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response J Immunol 2001 7033 7041
28. M. Remoli, E. Giacomini, G. Lutfalla, E. Dondi, G. Orefici, and A. Battistini Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis J Immunol 2002 366 374
29. E.N.P. Coccia, A. Battistini, C. Pini, F. Sinigaglia, and L. Rogge Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells J Biol Chem 1999 6698 6703
30. J. Liu, S. Cao, L. Herman, and X. Ma Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1 J Exp Med 2003 1265 1276
31. C. Becker, S. Wirtz, X. Ma, M. Blessing, P. Galle, and M. Neurath Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2) J Immunol 2001 2608 2618
32. A. D'Ambrosio, E. Giacomini, A. Bachetoni, M. Quaranta, and F. Quintieri Dilitiazem reduces nitric oxide production by human immune cells Transplant Proc 2001 2139 2141
33. Z. Chen, J. Hagler, V. Palombella, F. Melandri, D. Scherer, and D. Ballard Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway Genes Dev 1995 1586 1597
34. E. Traenckner, H. Pahl, T. Henkel, K. Schmidt, S. Wilk, and P. Baeuerle Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli EMBO J 1995 2876 2883
35. J. Brockman, D. Scherer, T. McKinsey, S. Hall, X. Qi, and W. Lee Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation Mol Cell Biol 1995 2809 2818
36. K. Brown, G. Franzoso, L. Baldi, L. Carlson, L. Mills, and Y. Lin The signal response of IkappaB alpha is regulated by transferable N- and C-terminal domains Mol Cell Biol 1997 3017 3021
37. J. Woronicz, X. Gao, Z. Cao, M. Rothe, and D.V. Goeddel IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK Science 1997 866 869
38. J. DiDonato, M. Hayakawa, D. Rothwarf, E. Zandi, and M. Karin A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB Nature 1997 548 554
39. C. Regnier, H. Song, X. Gao, D. Goeddel, Z. Cao, and M. Rothe Identification and characterization of an IkappaB kinase Cell 1997 373 383
40. E. Zandi, D. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 1997 243 252
41. D. Scherer, J. Brockman, Z. Chen, T. Maniatis, and D. Ballard Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination Proc Natl Acad Sci USA 1995 11259 11263
42. G.J. Clark, S. Gunningham, A. Troy, S. Vuckovic, and D. Hart Expression of the RelB transcription factor correlates with the activation of human dendritic cells Immunology Today 1999 189 196
43. A. Pettit, C. Quinn, K. MacDonald, L. Cavanagh, G. Thomas, and W. Townsend Nuclear localization of RelB is associated with effective antigen-presenting cell function J Immunol 1997 3681 3691
44. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene J Clin Invest 1998 252 262
45. M. Schmitz, and P. Baeuerle The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B EMBO J 1991 3805 3817
46. D. Plaksin, P. Baeuerle, and L. Eisenbach KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2κB gene expression in metastatic tumor cells J Exp Med 1993 1651 1662
47. I. Udalova, A. Richardson, A. Denys, C. Smith, H. Ackerman, and B. Foxwell Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region Mol Cell Biol 2000 9113 9119
48. H. Ziegler-Heitbrock, I. Petersmann, and M. Frankenberger p50 (NF-kappa B1) is upregulated in LPS tolerant P388D1 murine macrophages Immunobiology 1997 73 80
49. S. Grundstrom, P. Anderson, P. Scheipers, and A. Sundstedt Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells J Biol Chem 2004 8460 8468
50. B. Oppmann, R. Lesley, B. Blom, J.C. Timans, Y. Xu, and B. Hunte Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 2000 715 725
51. A. Bingaman, and D. Farber Memory T cells in transplantation: generation, function, and potential role in rejection Am J Transplant 2004 846 852
52. F. Driessler, K. Venstrom, R. Sabat, K. Asadullah, and A. Schottelius Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50 Clin Exp Immunol 2004 64 67
53. K. Moore, R.d.W. Malefyt, R. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 2001 683 765
54. J. Wei, and S. Zheng NF-kappa B in allograft rejection Hepatobiliary Pancreat Dis Int 2003 180 183